Search Results

CorNeat Vision, a leader in innovative medical device solutions, proudly introduces the CorNeat EverPatch, a pioneering synthetic tissue-integrating matrix designed to revolutionize ophthalmic surgeries.

CorNeat Vision’s EverPatch, a synthetic tissue substitute, has been granted 510(k) clearance by the US Food & Drug Administration (FDA).

CorNeat Vision, an Israeli biomimetic implant and technology company, unveiled the EverMatrix™, a revolutionary tissue-integrating material technology. The EverMatrix™ is the world’s first nondegradable, 100% synthetic, biomimetic Extra Cellular Matrix (ECM) - the skeleton of the tissue, that seamlessly integrates with live human tissue for life.

Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering a laser microporation therapy for the aging eye, announced the appointment of Frank Chen as Chief Operating Officer.